TABLE 1.
MMSE rate of change per year in ApoEe3/e3 and ApoEe3/e4 patients with MCI
| ApoE | Patient | Initial | Final | Initial date | Final date | Follow-up (mo) | Rate of change |
|---|---|---|---|---|---|---|---|
| ε3/ε3 | |||||||
| MCI | 2 | 24 | 28 | 9/23/2013 | 10/9/2016 | 37 | 0.11 |
| SCI | 4 | 30 | 30 | 12/22/2013 | 1/18/2016 | 25 | 0.00 |
| SCI | 8 | 26 | 30 | 5/26/2014 | 3/20/2016 | 10 | 0.40 |
| SCI | 10 | 28 | 30 | 6/18/2014 | 2/21/2016 | 20 | 0.10 |
| SCI | 17 | 28 | 30 | 7/4/2015 | 6/30/2016 | 12 | 0.17 |
| Mean, 20.8 | Mean/mo, 0.15 | ||||||
| Mean/yr, 1.86 | |||||||
| ε3/ε4 | |||||||
| MCI | 9 | 26 | 9 | 5/26/2014 | 10/10/2016 | 29 | −0.59 |
| SCI | 12 | 29 | 27 | 9/22/2014 | 3/13/2017 | 30 | −0.07 |
| MCI | 14 | 25 | 25 | 9/14/2014 | 1/28/2017 | 28 | 0.00 |
| SCI | 15 | 30 | 30 | 5/5/2015 | 6/28/2016 | 13 | 0.00 |
| MCI | 16 | 20 | 14 | 4/30/2015 | 10/13/2015 | 6 | −1.00 |
| SCI | 18 | 30 | 30 | 2/16/2016 | 11/30/2016 | 9 | 0.00 |
| Mean, 19.1 | Mean/mo, −0.28 | ||||||
| Mean (all), 19.9 | Mean/yr, −3.31 |
MMSE results in the longitudinal study of ω-3–supplemented patients.